|
1
|
Abaci A, Oğuzhan A, Kahraman S, Eryol NK,
Unal S, Arinç H and Ergin A: Effect of diabetes mellitus on
formation of coronary collateral vessels. Circulation.
99:2239–2242. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fujiyama S, Amano K, Uehira K, Yoshida M,
Nishiwaki Y, Nozawa Y, Jin D, Takai S, Miyazaki M, Egashira K, et
al: Bone marrow monocyte lineage cells adhere on injured
endothelium in a monocyte chemoattractant protein-1-dependent
manner and accelerate reendothelialization as endothelial
progenitor cells. Circ Res. 93:980–989. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Werner N, Priller J, Laufs U, Endres M,
Böhm M, Dirnagl U and Nickenig G: Bone marrow-derived progenitor
cells modulate vascular reendothelialization and neointimal
formation: Effect of 3-hydroxy-3-methylglutaryl coenzyme a
reductase inhibition. Arterioscler Thromb Vasc Biol. 22:1567–1572.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Loomans CJ, de Koning EJ, Staal FJ,
Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B,
Rabelink TJ and van Zonneveld AJ: Endothelial progenitor cell
dysfunction: A novel concept in the pathogenesis of vascular
complications of type 1 diabetes. Diabetes. 53:195–199. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fadini GP, Miorin M, Facco M, Bonamico S,
Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A,
Agostini C and Avogaro A: Circulating endothelial progenitor cells
are reduced in peripheral vascular complications of type 2 diabetes
mellitus. J Am Coll Cardiol. 45:1449–1457. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ingram DA, Lien IZ, Mead LE, Estes M,
Prater DN, Derr-Yellin E, DiMeglio LA and Haneline LS: In vitro
hyperglycemia or a diabetic intrauterine environment reduces
neonatal endothelial colony-forming cell numbers and function.
Diabetes. 57:724–731. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tepper OM, Galiano RD, Capla JM, Kalka C,
Gagne PJ, Jacobowitz GR, Levine JP and Gurtner GC: Human
endothelial progenitor cells from type II diabetics exhibit
impaired proliferation, adhesion, and incorporation into vascular
structures. Circulation. 106:2781–2786. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Malinda KM, Goldstein AL and Kleinman HK:
Thymosin beta 4 stimulates directional migration of human umbilical
vein endothelial cells. FASEB J. 11:474–481. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smart N, Risebro CA, Melville AA, Moses K,
Schwartz RJ, Chien KR and Riley PR: Thymosin beta4 induces adult
epicardial progenitor mobilization and neovascularization. Nature.
445:177–182. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grant DS, Rose W, Yaen C, Goldstein A,
Martinez J and Kleinman H: Thymosin beta4 enhances endothelial cell
differentiation and angiogenesis. Angiogenesis. 3:125–135. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao Y, Qiu F, Xu S, Yu L and Fu G:
Thymosin β4 activates integrin-linked kinase and decreases
endothelial progenitor cells apoptosis under serum deprivation. J
Cell Physiol. 226:2798–2806. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sosne G, Szliter EA, Barrett R, Kernacki
KA, Kleinman H and Hazlett LD: Thymosin beta 4 promotes corneal
wound healing and decreases inflammation in vivo following alkali
injury. Exp Eye Res. 74:293–299. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Riley PR and Smart N: Thymosin beta4
induces epicardium-derived neovascularization in the adult heart.
Biochem Soc Trans. 37:1218–1220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bock-Marquette I, Saxena A, White MD,
Dimaio JM and Srivastava D: Thymosin beta4 activates
integrin-linked kinase and promotes cardiac cell migration,
survival and cardiac repair. Nature. 432:466–472. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bock-Marquette I, Shrivastava S, Pipes GC,
Thatcher JE, Blystone A, Shelton JM, Galindo CL, Melegh B,
Srivastava D, Olson EN and DiMaio JM: Thymosin beta4 mediated PKC
activation is essential to initiate the embryonic coronary
developmental program and epicardial progenitor cell activation in
adult mice in vivo. J Mol Cell Cardiol. 46:728–738. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu FY, Song XX, Zheng H, Zhao YB and Fu
GS: Thymosin beta4 induces endothelial progenitor cell migration
via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc
Pharmacol. 53:209–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li J, Yu L, Zhao Y, Fu G and Zhou B:
Thymosin β4 reduces senescence of endothelial progenitor cells via
the PI3K/Akt/eNOS signal transduction pathway. Mol Med Rep.
7:598–602. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR,
Huang PH, Liu PL, Chen YL and Chen JW: High glucose impairs early
and late endothelial progenitor cells by modifying nitric
oxide-related but not oxidative stress-mediated mechanisms.
Diabetes. 56:1559–1568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bitzur R: Diabetes and cardiovascular
disease: When it comes to lipids, statins are all you need.
Diabetes Care. 34 Suppl 2:S380–S382. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bloomgarden ZT: Diabetes and
cardiovascular disease. Diabetes care. 34:e24–e30. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tabit CE, Chung WB, Hamburg NM and Vita
JA: Endothelial dysfunction in diabetes mellitus: Molecular
mechanisms and clinical implications. Rev Endocr Metab Disord.
11:61–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hill JM, Zalos G, Halcox JP, Schenke WH,
Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial
progenitor cells, vascular function, and cardiovascular risk. N
Engl J Med. 348:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rafii S and Lyden D: Therapeutic stem and
progenitor cell transplantation for organ vascularization and
regeneration. Nat Med. 9:702–712. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vasa M, Fichtlscherer S, Aicher A, Adler
K, Urbich C, Martin H, Zeiher AM and Dimmeler S: Number and
migratory activity of circulating endothelial progenitor cells
inversely correlate with risk factors for coronary artery disease.
Circ Res. 89:E1–E7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Landmesser U, Engberding N, Bahlmann FH,
Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner
D, Templin C, Kotlarz D, et al: Statin-induced improvement of
endothelial progenitor cell mobilization, myocardial
neovascularization, left ventricular function, and survival after
experimental myocardial infarction requires endothelial nitric
oxide synthase. Circulation. 110:1933–1939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Klein JJ, Goldstein AL and White A:
Enhancement of in vivo incorporation of labeled precursors into DNA
and Total protein of mouse lymph nodes after administration of
thymic extracts. Proc Natl Acad Sci USA. 53:812–817. 1965.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rossdeutsch A, Smart N, Dube KN, Turner M
and Riley PR: Essential role for thymosin beta4 in regulating
vascular smooth muscle cell development and vessel wall stability.
Circ Res. 111:e89–e102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaur H and Mutus B: Platelet function and
thymosin beta 4. Biol Chem. 393:595–598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Malinda KM, Sidhu GS, Mani H, Banaudha K,
Maheshwari RK, Goldstein AL and Kleinman HK: Thymosin beta 4
accelerates wound healing. J Invest Dermatol. 113:364–368. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lv S, Cheng G, Zhou Y and Xu G: Thymosin
beta4 induces angiogenesis through Notch signaling in endothelial
cells. Mol Cell Biochem. 381:283–290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Chopp M, Szalad A, Liu Z, Lu M,
Zhang L, Zhang J, Zhang RL, Morris D and Zhang ZG: Thymosin beta4
promotes the recovery of peripheral neuropathy in type II diabetic
mice. Neurobiol Dis. 48:546–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim S and Kwon J: Effect of thymosin beta
4 in the presence of up-regulation of the insulin-like growth
factor-1 signaling pathway on high-glucose-exposed vascular
endothelial cells. Mol Cell Endocrinol. 401:238–247. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Everaert BR, Van Craenenbroeck EM, Hoymans
VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans JP and Vrints
CJ: Current perspective of pathophysiological and interventional
effects on endothelial progenitor cell biology: Focus on
PI3K/AKT/eNOS pathway. Int J Cardiol. 144:350–366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dimmeler S, Aicher A, Vasa M, Mildner-Rihm
C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H and
Zeiher AM: HMG-CoA reductase inhibitors (statins) increase
endothelial progenitor cells via the PI 3-kinase/Akt pathway. J
Clin Invest. 108:391–397. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fulton D, Gratton JP, McCabe TJ, Fontana
J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A and Sessa WC:
Regulation of endothelium-derived nitric oxide production by the
protein kinase Akt. Nature. 399:597–601. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Aicher A, Heeschen C, Mildner-Rihm C,
Urbich C, Ihling C, Technau-Ihling K, Zeiher AM and Dimmeler S:
Essential role of endothelial nitric oxide synthase for
mobilization of stem and progenitor cells. Nat Med. 9:1370–1376.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun N, Wang H and Wang L: Vaspin
alleviates dysfunction of endothelial progenitor cells induced by
high glucose via pi3k/Akt/eNOS pathway. Int J Clin Exp Pathol.
8:482–489. 2015.PubMed/NCBI
|
